These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 23037807)
41. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Dong YB; Yang HL; McMasters KM Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937 [TBL] [Abstract][Full Text] [Related]
42. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646 [TBL] [Abstract][Full Text] [Related]
43. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389 [TBL] [Abstract][Full Text] [Related]
44. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Liang J; Chen M; Hughes D; Chumanevich AA; Altilia S; Kaza V; Lim CU; Kiaris H; Mythreye K; Pena MM; Broude EV; Roninson IB Cancer Res; 2018 Dec; 78(23):6594-6606. PubMed ID: 30185549 [TBL] [Abstract][Full Text] [Related]
45. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
46. Hyperthermia synergizes with tissue factor knockdown to suppress the growth and hepatic metastasis of colorectal cancer in orthotopic tumor model. Li H; Tian ML; Yu G; Liu YC; Wang X; Zhang J; Ji SQ; Zhu J; Wan YL; Tang JQ J Surg Oncol; 2012 Nov; 106(6):689-95. PubMed ID: 22532129 [TBL] [Abstract][Full Text] [Related]
47. The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9. Hu J; Ni S; Cao Y; Zhang T; Wu T; Yin X; Lang Y; Lu H PLoS One; 2016; 11(2):e0149537. PubMed ID: 26872030 [TBL] [Abstract][Full Text] [Related]
48. Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis. Su CW; Chang YC; Chien MH; Hsieh YH; Chen MK; Lin CW; Yang SF Cell Death Dis; 2019 Oct; 10(11):793. PubMed ID: 31624299 [TBL] [Abstract][Full Text] [Related]
49. In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2. Finan KM; Hodge G; Reynolds AM; Hodge S; Holmes MD; Baker AH; Reynolds PN Lung Cancer; 2006 Sep; 53(3):273-84. PubMed ID: 16860902 [TBL] [Abstract][Full Text] [Related]
50. Tissue inhibitor of metalloproteinase-3 (TIMP3) expression decreases during melanoma progression and inhibits melanoma cell migration. Das AM; Bolkestein M; van der Klok T; Oude Ophuis CM; Vermeulen CE; Rens JA; Dinjens WN; Atmodimedjo PN; Verhoef C; Koljenović S; Smits R; Ten Hagen TL; Eggermont AM Eur J Cancer; 2016 Oct; 66():34-46. PubMed ID: 27522248 [TBL] [Abstract][Full Text] [Related]
51. Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer. Zeng Z; Sun Y; Shu W; Guillem JG Dis Colon Rectum; 2001 Sep; 44(9):1290-6. PubMed ID: 11584202 [TBL] [Abstract][Full Text] [Related]
52. Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer. MacDonald A; Priess M; Curran J; Guess J; Farutin V; Oosterom I; Chu CL; Cochran E; Zhang L; Getchell K; Lolkema M; Schultes BC; Krause S Mol Cancer Ther; 2019 Feb; 18(2):245-256. PubMed ID: 30401693 [TBL] [Abstract][Full Text] [Related]
53. Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer. Imaizumi Y; Yoshida S; Kanegae Y; Eto K; Yoshida K Cancer Sci; 2022 Mar; 113(3):960-970. PubMed ID: 34932844 [TBL] [Abstract][Full Text] [Related]
54. The tumor suppressive role of TIMP3 in the human osteosarcoma cells. Tan B; Xu X; Zhang Q; Yuan Z; Dong J J Orthop Sci; 2022 May; 27(3):689-695. PubMed ID: 33814198 [TBL] [Abstract][Full Text] [Related]
55. Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology. Lee WT; Wu PY; Cheng YM; Huang YF Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542164 [TBL] [Abstract][Full Text] [Related]
56. Phosphatidylinositol 3-kinase mediates the ability of retinol to decrease colorectal cancer cell invasion. Lengyel JN; Park EY; Brunson AR; Pinali D; Lane MA Nutr Cancer; 2014; 66(8):1352-61. PubMed ID: 25356626 [TBL] [Abstract][Full Text] [Related]
57. Clinicopathologic significance of BAG1 and TIMP3 expression in colon carcinoma. Bai YX; Yi JL; Li JF; Sui H World J Gastroenterol; 2007 Jul; 13(28):3883-5. PubMed ID: 17657847 [TBL] [Abstract][Full Text] [Related]